Background: An important factor influencing duration of breastfeeding is mother’s employment status. The nutritional, immunological, psychological and economic benefits of breastfeeding are well documented. Both UNICEF and the World Health Organization recommend mothers should breastfeed exclusively for at least 6 months.
Objectives: To determine how the employment and the employment variables (type of work, time of return to work and hours of work) influence the breast feeding practices.
Methods: A cross- sectional study was carried out on a sample of 200 employed mothers who had their last child been completed at least tow years. Data were collected using a questionnaire form. It was carried out during the period from 1st of April to 1st of September, 2000, in Baghdad city/ AL-Risafa in 6 different places where employed mothers of young children were expected to be found.
Results: The study revealed that the impact of employment status was noted on the breast feeding initiation time, breast feeding duration and complementary food initiation time. The majority of employed mothers (56.1%) who worked shorter hours breast-feed for longer durations and starts weaning after the fourth months of the infant’s age. The highest percentage of employed mothers (75.9%) with maternity leave of six months or more breast feed for a year or more and (66.1%) start weaning later than the fourth month of the infant’s life.
Conclusions: The study recognizes that employed mothers who worked shorter hours and mothers with longer maternity leaves breast feed for longer durations and start weaning later than mothers who worked long hours and mothers with shorter maternity leaves. It was concluded that most work-places lack accommodations to support breast-feeding.
background: human epidermal growth factor receptor-2 (her2/neu) is related to growth factor receptors with alkaline kinase activity and it is regarded as important prognostic and therapeutic factor that can depended on in breast cancer therapy. HER2/neu expression by immunohistochemistry (IHC) is submitted to a great in terob server inconsistency. Subsequently additional confirmatory tests for assessment of gene alterations and amplification status are needed for patients with early or metastatic breast cancer. In situ hybridization techniques and specifically Chromogenic in situ hybridization (CISH) was arise as a practical, cost-effective, and alternative to fluorescent in situ hybridization in testing for gene alterationAims of the study
... Show MoreAbstract Background: The human epidermal growth factor receptor 2(HER2) proto-oncogene is overexpressed or amplified in approximately 15%-25% of invasive breast cancers. Approximately 35% of HER2-amplified breast cancers have coamplification of the topoisomerase II-alpha (TOP2A) gene encoding an enzyme that is a major target of anthracyclines. Hence, the determination of genetic alteration (amplification or deletion) of both genes is considered as an important predictive factor that determines the response of breast cancer patients to treatment. The aims of this study are to determinate TOP2A status gene amplification in a set of Iraqi patients with breast cancer that have had an equivocal (2+) and positive HER2/neu by immunohistochemistry
... Show More
(2)
(1)
Background: While two-thirds of breast cancers express hormone receptors for either estrogen (ER) and/or progesterone (PR) , genetically altered PI3K pathway was found in more than 70% of ER-positive breast cancers.An aberrant activity of cyclin-dependent kinase 1 (CDK1) in a wide variety of human cancers has selectively constituted an attractive pharmacological targets in MYC-dependent human breast cancer cells.
Aim of the study: Role of p110-beta as well as and CDK 1 in the pathogenesis of subset of breast cancers and contribution in their carcinogenesis.
Type of the study: is a retrospective study
Methods: This retr
... Show More
Breast cancer is the most common malignancy affecting women's health, with an increasing incidence worldwide. This study aimed to measure the intracellular concentration of the hypoxia-inducible factor 1 α (HIF-1α), tumor suppression protein p53, and estradiol (E2) in tumor tissues of adult females with breast cancer and their relation to tumor grade, tumor size, and lymph node metastases (LNM). The study was conducted on 65 adult female participants with breast mass admitted to the operating theater in Al-Hussein Teaching Hospital and Al-Habboby Teaching Hospital in Nasiriyah, Iraq, from January to November 2021. Fresh breast tumor tissues were collated and homogenized for intracellular biochemical analysis using the enzyme-linked immuno
... Show More
(1)
(11)
(3)
(7)
(6)
(68)
(53)
(1)
(1)
(10)
(7)
(9)